Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 32 Ovarian Neoplasms 21 Neoplasms 14 Carcinoma, Hepatocellular 13 Fallopian Tube Neoplasms 12 Carcinoma, Non-Small-Cell Lung 9 Endometrial Neoplasms 7 Colonic Neoplasms 7 Neoplasm Metastasis 6 Squamous Cell Carcinoma of Head and Neck 4 Glioblastoma 4 Breast Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Lung Neoplasms 3 Liver Neoplasms 3 Biliary Tract Neoplasms 3 Sarcoma 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pancreatic Neoplasms 2 Neuroma, Acoustic 2 Neurofibromatosis 2 2 Mouth Neoplasms 2 Meningioma 2 Lymphoid Interstitial Pneumonia 2 Gastrointestinal Neoplasms 2 Digestive System Neoplasms 2

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Liver Cancers × Bevacizumab × 30 days × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡